EU Filings For Orphan Status On The Decline
£12m In Fee Reductions For Rare Disease Drugs In 2019
Executive Summary
Requests from sponsors for orphan drug status in the EU are showing a downward trend. It is not yet clear why, but a forthcoming report from the European Commission may provide some answers.